DHA
Executive Director, Defense Health Board, DHA – O6
The Director, Defense Health Agency (DHA) requests Service nominations to fill the O-6 level position of Executive Director, Defense Health Board (DHB), Defense Health Agency. The Executive Director organizes, facilitates, and directs the activities of over 50 special government employee health care subject matter experts to provide independent advice of the Secretary of Defense, the Under Secretary of Defense for Personnel and Readiness, the Assistant Secretary of Defense for Health Affairs, and Director, Defense Health Agency, to maximize the health, safety, and effectiveness of the United States Armed Forces.
The candidate must have a doctorate of medicine with a Master’s degree (or higher) in Public Health, or health discipline requiring a thesis/dissertation, or a doctorate of philosophy in health discipline. The assignment is 36 months, and the desired report date is August 2023, with early reporting authorized.
Prospective Medical Corps applicants should send a CV and BIO to CAPT Rhett Barrett NLT 1200 EST, Friday, January 20, 2023.
Maj Gen Crosland Becomes DHA Director
Here’s an article on the change:
https://www.ausa.org/news/crosland-becomes-defense-health-agency-director
Here are her remarks from the change of command ceremony:
Aide De Camp, Director DHA – O4
Details and application requirements attached:
Fully completed nomination packages are to be emailed to CAPT Rhett Barrett (contact in the global) NLT 1200 EST Friday, September 23, 2022.
Interim Lead, DHA Hospital Medicine Working Group
Position: Interim Lead, DHA Hospital Medicine Working Group
Time Frame: May – September 2022
Time Commitment: Approximately 3-5 hours weekly.
Hospital Medicine Working Group Meeting: Every other week, Tuesday 1330 EST
Inpatient Clinical Support Services Meeting: Weekly, Wednesday 1330 EST
Position Description: The Hospital Medicine Working Group (HMWG) is a subcommittee of the DHA Inpatient Clinical Support Services (ICSS). The overall goal of the HMWG is the development of an enterprise-wide instruction for inpatient medicine run by hospital medicine specialists (hospitalists). A basic business case analysis has been completed and there is a pending submission to the Center for Naval Analysis to evaluate the benefits of such a program, to include monetary and quality of patient care (anticipate a response in the next 4-6 weeks). On-going taskers include the development of a standardized staffing model for the DHEA and submission into the DHA Resource Portal. The ultimate goal is a DHA Procedural Instruction (DHAPI) for a hospitalist-led inpatient medicine service.
If interested please contact CDR Jennifer Eng-Kulawy (contact in the global) with your CV, BIO, and brief letter of intent NLT 20 May 2022.